Literature DB >> 23407988

Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.

Makoto Hara1, Katsuiku Hirokawa, Satoshi Kamei, Toshiki Uchihara.   

Abstract

Regional progression of neurofibrillary tangles (NFTs) around the hippocampus was traced on thick sections double immunofluorolabeled with RD3 and RD4 antibodies, specific for three- and four-repeat tau, respectively. As reported, the cubic density of all tau-positive neurons was predominant in the entorhinal cortex and cornu ammonis (CA)1, and decreased progressively to the CA2-4 subregions. Among the three isoform profiles (RD3+/4-, RD3+/4+, and RD3-/4+), this regional gradient was replicated with RD3+/4- and RD3+/4+ neurons, while RD3-/4+ neurons exhibited the reverse gradient. Comparison of the subregion pairs confirmed a consistent profile shift along this gradient in every case regardless of the abundance of NFTs. To clarify the underlying mechanism of this regional profile shift, intraneuronal intensity of RD3 and RD4 immunoreactivity (IR) was quantified. Although their intensities were both lower in dendrites than in the soma, this gradient was steeper with RD4, leaving RD3 IR in dendrites. Dendritic arborization was abundant in RD3-/4+ pretangles, attenuated in RD3+/4+ neurons, and further attenuated in RD3+/4- ghost tangles. These findings suggest that dendritic RD4 IR retracts first, leaving RD3 IR in the dendrites. Taken together, this dendrite-oriented retraction initiates the gradual shift from RD3-/4+ pretangle neurons to RD3+/4- ghost tangles by way of RD3+/4+ NFTs. This intraneuronal profile shift may be a basis for the regional gradation featured by the similar profile shift during progression of NFT pathology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23407988     DOI: 10.1007/s00401-013-1097-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Selective Neuronal Vulnerability in Alzheimer's Disease: A Network-Based Analysis.

Authors:  Jean-Pierre Roussarie; Vicky Yao; Patricia Rodriguez-Rodriguez; Rose Oughtred; Jennifer Rust; Zakary Plautz; Shirin Kasturia; Christian Albornoz; Wei Wang; Eric F Schmidt; Ruth Dannenfelser; Alicja Tadych; Lars Brichta; Alona Barnea-Cramer; Nathaniel Heintz; Patrick R Hof; Myriam Heiman; Kara Dolinski; Marc Flajolet; Olga G Troyanskaya; Paul Greengard
Journal:  Neuron       Date:  2020-06-29       Impact factor: 17.173

2.  Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture.

Authors:  Hans Zempel; Frank J A Dennissen; Yatender Kumar; Julia Luedtke; Jacek Biernat; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

Review 3.  The basis of cellular and regional vulnerability in Alzheimer's disease.

Authors:  Dunja Mrdjen; Edward J Fox; Syed A Bukhari; Kathleen S Montine; Sean C Bendall; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2019-08-07       Impact factor: 17.088

4.  Cyclic AMP-dependent protein kinase enhances SC35-promoted Tau exon 10 inclusion.

Authors:  Caoyi Chen; Nana Jin; Wei Qian; Wen Liu; Xiangling Tan; Fei Ding; Xiaosong Gu; Khalid Iqbal; Cheng-Xin Gong; Ji Zuo; Fei Liu
Journal:  Mol Neurobiol       Date:  2013-09-14       Impact factor: 5.590

5.  Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.

Authors:  Sarah Gourmaud; Haochang Shou; David J Irwin; Kimberly Sansalone; Leah M Jacobs; Timothy H Lucas; Eric D Marsh; Kathryn A Davis; Frances E Jensen; Delia M Talos
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

6.  4',6-Diamidino-2-Phenylindole Distinctly Labels Tau Deposits.

Authors:  Chengyu Li; Tetsuya Takahashi; Tejashwi Shrestha; Eiji Kinoshita; Tomoyasu Matsubara; Masayasu Matsumoto; Hirofumi Maruyama
Journal:  J Histochem Cytochem       Date:  2018-08-14       Impact factor: 2.479

7.  Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.

Authors:  Jonathan D Cherry; Camille D Esnault; Zachary H Baucom; Yorghos Tripodis; Bertrand R Huber; Victor E Alvarez; Thor D Stein; Dennis W Dickson; Ann C McKee
Journal:  Acta Neuropathol Commun       Date:  2021-05-12       Impact factor: 7.578

8.  Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain.

Authors:  Ayaho Dan; Muneaki Takahashi; Masami Masuda-Suzukake; Fuyuki Kametani; Takashi Nonaka; Hiromi Kondo; Haruhiko Akiyama; Takao Arai; David M A Mann; Yuko Saito; Hiroyuki Hatsuta; Shigeo Murayama; Masato Hasegawa
Journal:  Acta Neuropathol Commun       Date:  2013-08-21       Impact factor: 7.801

9.  Molecular nexopathies: a new paradigm of neurodegenerative disease.

Authors:  Jason D Warren; Jonathan D Rohrer; Jonathan M Schott; Nick C Fox; John Hardy; Martin N Rossor
Journal:  Trends Neurosci       Date:  2013-07-19       Impact factor: 13.837

10.  Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Geidy E Serrano; Thomas G Beach; Douglas G Walker
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-10       Impact factor: 3.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.